Advertisement

OneOncology Names Davey Daniel, MD, Chief Medical Officer


Advertisement
Get Permission

OneOncology, the national platform for independent community oncology practices, announced that Davey Daniel, MD, has been appointed Chief Medical Officer succeeding Lee Schwartzberg, MD. Dr. Schwartzberg served as the founding member of the platform’s clinical office and will remain a senior advisor to the company.

Davey Daniel, MD

Davey Daniel, MD

A graduate of Johns Hopkins School of Medicine, Dr. Daniel did his fellowship at Duke University Medical Center in Durham, North Carolina. He is currently Vice Chair of -OneCouncil, the platform’s all-physician advisory board for clinical and strategic initiatives.

Dr. Daniel leads medical education initiatives, including virtual tumor boards, a physicians’ conference that OneOncology will hold in the fall of 2022, and other learning opportunities for physicians and fellows. He has also been integral to launching OneCommunity, a digital oncology platform used to examine medical cases at practices across the partnership.

Professional Background

A lung cancer specialist who will continue treating patients at Tennessee Oncology in Chattanooga, Dr. Daniel received his medical degree from Johns Hopkins School of Medicine before completing his fellowship at Duke University Medical Center. While at Duke, Dr. Daniel met his future wife, Brooke Daniel, a breast cancer oncologist, who also practices at Tennessee Oncology in Chattanooga.

Jeff Patton, MD

Jeff Patton, MD

“Dr. Daniel is a servant leader in the truest sense,” said Jeff Patton, MD, OneOncology’s Chief Executive Officer. “Having trained at some of the nation’s most prestigious academic institutions, his passion for advancing science, delivering the highest quality patient-centered care and commitment to improving clinical outcomes, makes him the perfect person to accelerate OneOncology’s clinical network and fuel an expansion of clinical services. Dr. Daniel’s practical approach to medicine will be well received by all the physicians on the -OneOncology platform.” 


Advertisement

Advertisement



Advertisement